Hazardous Drug Sample Analysis
Dept of Defense · DEFENSE HEALTH AGENCY (DHA)
This notice is not accepting responses (deadline was Apr 24, 2026, 11:00 AM EDT).
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- Apr 24, 2026, 11:00 AM EDT
- Posted
- Apr 16, 2026
- Solicitation
- HT942726QE008
- Set-aside
- No Set aside used
- Place of performance
- Aberdeen, MD, USA
- Contracting office
- DEFENSE HEALTH AGENCY · FORT DETRICK · MD
- Source
- SAM.gov · updated Jul 5, 2026
Description
As part of the DCPH-A mission, the Lab Sciences (LS) Directorate requires the analysis of wipe/swab samples for the presence of hazardous drugs in support of pharmacies and Military Treatment Facilities (MTFs) within the Department of War (DoW). This analysis is mandated for the MTFs using Chemotherapy drugs to ensure their cleaning procedures are effective to ensure safety of the MTF staff and to avoid cross-contamination. The directives that mandate this semi-annual testing requirement are United Stated Pharmacopiea (USP) 800: Handling Hazardous Drugs and Technical Bulletin-Medical (TB-MED) 515: Occupational Health and Indutrial Hygiene Guidance for the Management, Use and Disposal of Hazardous Drugs. There is no acceptable level of occupational exposure to Hazardous Drugs. The LS Directorate of the DCPH-A is the only government laboratory to perform this hazardous drugs analysis as required. While LS does have the analytical capability to perform hazardous drugs analyses, as a sole source for this effort, there is a need to have back-up laboratory capability for instances of instrument down-time or over-capacity situations. Objectives for this Requirement are as follows: The Contractor shall perform analysis on wipe/swab samples provided by the Government for Hazardous Drugs contamination. The Contractor shall perform the sample analysis within the stated turnaround time (TAT) identified in the Outsource Document and identified in the PWS. The Contractor shall provide Quality wipe/swab analysis for various hazardous drugs as identified in this PWS in accordance with an accredited methodology. The Contractor shall dispose of unused samples as prescribed by their quality manual/Standing Operating Procedures and return Government shipping containers. The Contractor shall supply sampling media upon request. The Contractor shall pay liquidated damages for late or deficient reporting as detailed in Section 5.of the PWS. QUESTIONS are due by 20 April 2026 by 1pm Eastern Standard Time (EST) QUOTATIONS are due by 24 April 2026 by 11am EST. See the Performance Work Statement (PWS) for complete information regarding this effort.
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$50,000
Middle of the pack for similar past awards
Most similar awards fall between $20,292 and $176,769
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1VERILY LIFE SCIENCES LLC2 awards$41.97M
- 2RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL5 awards$25.40M
- 3THE MEDICAL UNIVERSITY OF SOUTH CAROLINA78 awards$20.59M
- 4INFINITY BIOLOGIX LLC2 awards$12.61M
- 5AZENTA US INC3 awards$7.44M
- 6DNA LABS INTERNATIONAL INC4 awards$6.00M
- 7BAYLOR COLLEGE OF MEDICINE6 awards$4.44M
- 8AKESOGEN, INC.1 award$4.00M
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID 923ac6370ff64b7fa9675132feea415a.